EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Transplantation, bridging, and support technologies in pulmonary hypertension

Laurent Savale iD, Alberto Benazzo iD, Paul Corris, Shaf Keshavjee iD, Deborah Jo Levine, Olaf Mercier, R Duane Davis, John T Granton

European Respiratory Journal · 2024-10 · 64 (4) · 2401193

DOI: 10.1183/13993003.01193-2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 29.08.2024. Verfasst von Laurent Savale und 7 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Lung Transplantation. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the progress made in medical therapies for treating pulmonary hypertension (PH), a subset of patients remain susceptible to developing a maladaptive right ventricular phenotype. The effective management of end-stage PH presents substantial challenges, necessitating a multidisciplinary approach and early identification of patients prone to acute decompensation. Identifying potential transplant candidates and assessing the feasibility of such a procedure are pivotal tasks that should be undertaken early in the treatment algorithm. Inclusion on the transplant list is contingent upon a comprehensive risk assessment, also considering the specific type of PH and various factors affecting waiting times, all of which should inform the decision-making process. While bilateral lung transplantation is the preferred option, it demands expert intra- and post-operative management to mitigate the heightened risks of pulmonary oedema and primary graft dysfunction in PH patients. Despite the availability of risk assessment tools, the occurrence of acute PH decompensation episodes can be unpredictable, potentially leading to refractory right ventricular failure even with optimal medical intervention, necessitating the use of rescue therapies. Advancements in right ventricular assist techniques and adjustments to graft allocation protocols for the most critically ill patients have significantly enhanced the survival in intensive care, affording the opportunity to endure while awaiting an urgent transplant. Given the breadth of therapeutic options available, specialised centres capable of delivering comprehensive care have become indispensable for optimising patient outcomes. These centres are instrumental in providing holistic support and management tailored to the complex needs of PH patients, ultimately enhancing their chances of a successful transplant and improved long-term prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryLung TransplantationHumansRisk AssessmentHeart-Assist DevicesVentricular Dysfunction, RightPulmonary EdemaPrimary Graft Dysfunction

Autor:innen und Institutionen

  • INSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
  • Université Paris-Saclay, Faculté de Médecine, HPPIT, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Le Kremlin-Bicêtre, France.
  • Assistance Publique -‌ Hôpitaux de Paris (AP-HP), Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
  • Newcastle University and Institute of Transplantation, Freeman Hospital, Newcastle, UK.
  • Toronto Lung Transplant Program, Division of Thoracic Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Laurent Savale, Alberto Benazzo, Shaf Keshavjee

Zitieren

APA

Savale, L., Benazzo, A., Corris, P., Keshavjee, S., Levine, D. J., Mercier, O., Davis, R. D., & Granton, J. T. (2024). Transplantation, bridging, and support technologies in pulmonary hypertension. European Respiratory Journal, 64(4), 2401193. https://doi.org/10.1183/13993003.01193-2024

Vancouver

Savale L, Benazzo A, Corris P, Keshavjee S, Levine DJ, Mercier O, et al. Transplantation, bridging, and support technologies in pulmonary hypertension. European Respiratory Journal. 2024;64(4):2401193. doi:10.1183/13993003.01193-2024

BibTeX
@article{Savale2024,
  author = {Savale, Laurent and Benazzo, Alberto and Corris, Paul and Keshavjee, Shaf and Levine, Deborah Jo and Mercier, Olaf and Davis, R Duane and Granton, John T},
  title = {Transplantation, bridging, and support technologies in pulmonary hypertension},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {64},
  number = {4},
  pages = {2401193},
  doi = {10.1183/13993003.01193-2024}
}
Kostenlos starten →